Valvular disease refers to conditions affecting the heart valves, crucial components responsible for maintaining the unidirectional flow of blood within the heart. The heart has four valves—mitral, aortic, tricuspid, and pulmonary—that open and close synchronously to facilitate efficient blood circulation. Valvular diseases can manifest as stenosis (narrowing) or regurgitation (leakage), both of which compromise the heart's ability to pump blood effectively. Causes may include congenital defects, infections, or age-related degeneration. Symptoms range from chest pain and fatigue to shortness of breath. Timely diagnosis through imaging studies and echocardiograms is crucial for appropriate management, which may involve medications, lifestyle changes, or, in severe cases, surgical intervention to repair or replace the affected valve. Effective management of valvular diseases is paramount for maintaining heart health and preventing complications.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation